Gilead Sciences Declares Quarterly Dividend as Analysts Adjust Ratings
Kimelman & Baird LLC, Vermillion & White Wealth Management Group and Quattro Advisors LLC increased positions in Gilead Sciences. HSBC lifted its rating to buy and raised its price target, while Daiwa Securities trimmed its target but kept an outperform view. The company also declared a quarterly dividend payable Sept. 29, following its Aug. 3 earnings release.